Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering.

By K. Rezwan, Qizhi Chen, J. Blaker, Aldo R. Boccaccini. Biomaterials, 2006

3,719 citations recorded by the source corpus.

Subfields: Biomaterials, Biomedical Engineering, Surgery

View Paper: https://www.semanticscholar.org/paper/74261031ef478360471b69434d49b2b7db77cca8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. G. Gorrasi
2. E. Fortunati
3. J. Kenny
4. M. Murariu
5. Philippe Dubois
6. Gisela M. Luz
7. L. Gerhardt
8. D. Kumar

In Biomedical Engineering

1. S. Bose
2. A. Bandyopadhyay
3. M. Murariu
4. L. Gerhardt
5. D. Kumar
6. H. Rashid
7. Gisela M. Luz
8. Z. Sheikh

In Surgery

1. M. Roy
2. L. Gerhardt
3. D. Kumar
4. Chao Yang
5. A. Bandyopadhyay
6. Yuanyuan Li
7. Yuhua Li
8. Aldo R. Boccaccini

Citations in the corpus

• Mineralized structures in nature: Examples and inspirations for the design of new composite materials and biomaterials (2010, background): “Osteoconductive scaffolds may be readily prepared by including bioactive ceramic or glasses within the polymeric matrix [83].”
• 3D bioactive composite scaffolds for bone tissue engineering (2017, background): “osteointegration ability and biodegradability [193,289,290].”
• Biodegradable magnesium alloys for orthopaedic applications: A review on corrosion, biocompatibility and surface modifications. (2016, background): “They are hydrolytically and enzymatically (trypsin or lysozyme) degraded into glycolic and lactic acid which are easily assimilated by metabolic pathways [90].”
• POLYMERIC SCAFFOLDS IN TISSUE ENGINEERING APPLICATION: A REVIEW (2011, background): “Development of composite materials for tissue engineering is attractive since their properties can be engineered to suit the mechanical and physiological demands of the host tissue by controlling the volume fraction, morphology, and arrangement of the reinforcing phase [196].”
• Bone tissue engineering: A review in bone biomimetics and drug delivery strategies (2009, background): “(glycolic-acid)(PGA), and poly(caprolactone) (PCL), and their copolymers are the most commonly utilized polymers in bone tissue engineering.(11,49,133,241) These polymers have been FDA-approved and utilized in a wide variety of clinical applications such as sutures, systemic drug delivery, spinal”
• Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering (2010, background): “It is now widely accepted that for establishing bond with bone, such a biologically active apatite surface layer must form at the material/bone interface [1,8,11,12,37] (see also discussion in §4).”